Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters | Zendy

Nan–Yao Lee | Zendy; ChingChi Lee | Zendy; Wei-Han Huang | Zendy; Ko-Chung Tsui | Zendy; PoRen Hsueh | Zendy; WenChien Ko | Zendy

Open Access

Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters

Author(s) -

Nan–Yao Lee,

ChingChi Lee,

Wei-Han Huang,

Ko-Chung Tsui,

PoRen Hsueh,

WenChien Ko

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis916

Subject(s) - cefepime , medicine , bacteremia , carbapenem , odds ratio , confidence interval , clinical endpoint , retrospective cohort study , randomized controlled trial , antibiotics , microbiology and biotechnology , imipenem , antibiotic resistance , biology

Extended-spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae isolates are important clinical pathogens. In addition, the efficacy of cefepime for such infections is controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research